Sledovat
Xiujuan Zhang
Xiujuan Zhang
E-mailová adresa ověřena na: jefferson.edu
Název
Citace
Citace
Rok
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
W Tai, L He, X Zhang, J Pu, D Voronin, S Jiang, Y Zhou, L Du
Cellular & molecular immunology 17 (6), 613-620, 2020
19692020
A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
W Tai, X Zhang, A Drelich, J Shi, JC Hsu, L Luchsinger, CD Hillyer, ...
Cell research 30 (10), 932-935, 2020
1592020
Neutralizing antibodies for the prevention and treatment of COVID-19
XZ Lanying Du, Yang Yang
Cell Mol Immunol 10 (2293-2306), 2021
131*2021
Identification of SARS-CoV RBD-targeting Monoclonal Antibodies With Cross-Reactive or Neutralizing Activity Against SARS-CoV-2.
LD Wanbo Tai,Xiujuan Zhang, Yuxian He, Shibo Jiang
Antiviral Research, 2020
1272020
Neutralizing antibodies for the treatment of COVID-19
S Jiang, X Zhang, Y Yang, PJ Hotez, L Du
Nature biomedical engineering 4 (12), 1134-1139, 2020
1042020
Enfuvirtide (T20)-based lipopeptide is a potent HIV-1 cell fusion inhibitor: implications for viral entry and inhibition
X Ding, X Zhang, H Chong, Y Zhu, H Wei, X Wu, J He, X Wang, Y He
Journal of virology 91 (18), 10.1128/jvi. 00831-17, 2017
972017
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection
PLOS PATHOGENS 1009897, 2021
752021
A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses
L Du, VHC Leung, X Zhang, J Zhou, M Chen, W He, HY Zhang, ...
PloS one 6 (1), e16555, 2011
602011
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2
S Jiang, X Zhang, L Du
Expert opinion on therapeutic targets 25 (6), 415-421, 2021
582021
Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies
L Du, G Zhao, X Zhang, Z Liu, H Yu, BJ Zheng, Y Zhou, S Jiang
Biochemical and biophysical research communications 397 (3), 580-585, 2010
472010
A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross- Protection
SJ Lanying Du 1. , Guangyu Zhao 2. , Shihui Sun 2 , Xiujuan Zhang 1 ...
PLOS ONE 8 (1), e53568, 2013
382013
Structural and functional characterization of HIV-1 cell fusion inhibitor T20
X Zhang, X Ding, Y Zhu, H Chong, S Cui, J He, X Wang, Y He
Aids 33 (1), 1-11, 2019
372019
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies
FL Lanying Du, Yang Yang, Xiujuan Zhang
Nanoscale, 2022
342022
A built-in CpG adjuvant in RSV F protein DNA vaccine drives a Th1 polarized and enhanced protective immune response
Y Ma, YY Jiao, YZ Yu, N Jiang, Y Hua, XJ Zhang, YH Fu, XL Peng, ...
Viruses 10 (1), 38, 2018
322018
Advances in mRNA and other vaccines against MERS-CoV
LD Wanbo Tai 1, Xiujuan Zhang 1, Yang Yang 2, Jiang Zhu 3
Transl Res. 7, 2021
31*2021
Exceptional potency and structural basis of a T1249-derived lipopeptide fusion inhibitor against HIV-1, HIV-2, and simian immunodeficiency virus
Y Zhu, X Zhang, X Ding, H Chong, S Cui, J He, X Wang, Y He
Journal of Biological Chemistry 293 (14), 5323-5334, 2018
292018
Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission
L Li, P Qiao, J Yang, L Lu, S Tan, H Lu, X Zhang, X Chen, S Wu, S Jiang, ...
Retrovirology 7, 1-18, 2010
292010
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection
LD Juan Shi # 1 2, Jian Zheng # 3, Wanbo Tai # 2, Abhishek K Verma 3 ...
J Virol 96 (17), 2022
272022
A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus
YY Jiao, YH Fu, YF Yan, Y Hua, Y Ma, XJ Zhang, JD Song, XL Peng, ...
Antiviral research 144, 57-69, 2017
222017
RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge
LDU JUAN SHI , JIAN ZHENG , XIUJUAN ZHANG, WANBO TAI, ABBY E. ODLE, STANLEY ...
Translational Research, 2022
202022
Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.
Články 1–20